ResearchMoz

Friedreich Ataxia Global Clinical Trials Review, H2, 2011

Publisher Name » GlobalData
Published Date » 2011-11-15
No. Of Pages » 81

GlobalData's clinical trial report, Friedreich Ataxia Global Clinical Trials Review, H2, 2011" provides data on the Friedreich Ataxia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Friedreich Ataxia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Friedreich Ataxia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 6
Friedreich Ataxia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Nations 13
Clinical Trials in G7 Nations by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Unaccomplished Trials of Friedreich Ataxia 18
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Top Companies Participating in Friedreich Ataxia Therapeutics Clinical Trials 23
Prominent Drug Comparison 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Santhera Pharmaceuticals Holding AG 25
Clinical Trial Overview of Santhera Pharmaceuticals Holding AG 25
Ipsen Inc 26
Clinical Trial Overview of Ipsen Inc 26
Edison Pharmaceuticals, Inc. 27
Clinical Trial Overview of Edison Pharmaceuticals, Inc. 27
Penwest Pharmaceuticals Co. 28
Clinical Trial Overview of Penwest Pharmaceuticals Co. 28
H. Lundbeck A/S 29
Clinical Trial Overview of H. Lundbeck A/S 29
ApoPharma 30
Clinical Trial Overview of ApoPharma 30
Apotex, Inc. 31
Clinical Trial Overview of Apotex, Inc. 31
Clinical Trial Overview of Top Universities / Institutes / Hospitals 32
Assistance Publique - Hopitaux de Paris 32
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 32
The University of South Florida 33
Clinical Trial Overview of The University of South Florida 33
The Federico II University 34
Clinical Trial Overview of The Federico II University 34
Royal Free Hampstead NHS Trust 35
Clinical Trial Overview of Royal Free Hampstead NHS Trust 35
The University of Utah 36
Clinical Trial Overview of The University of Utah 36
National Institute of Neurological Disorders and Stroke 37
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 37
Murdoch Childrens Research Institute 38
Clinical Trial Overview of Murdoch Childrens Research Institute 38
Five Key Clinical Profiles 39

Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 81

List of Tables


Friedreich Ataxia Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Friedreich Ataxia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Friedreich Ataxia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Friedreich Ataxia Therapeutics Clinical Trials, Asia-Pacific,Top Countries, 2011* 10
Friedreich Ataxia Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 11
Friedreich Ataxia Therapeutics Clinical Trials, North America, Top Countries, 2011* 12
Friedreich Ataxia Therapeutics Clinical Trials, G7 Countries, 2011* 13
Friedreich Ataxia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 14
Friedreich Ataxia Therapeutics Market, Global, Clinical Trials by Phase, 2011* 15
Friedreich Ataxia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 16
Friedreich Ataxia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 17
Friedreich Ataxia Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 18
Friedreich Ataxia Therapeutics Market, Global, Terminated Clinical Trials, 2011* 19
Friedreich Ataxia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Friedreich Ataxia Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 22
Friedreich Ataxia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 23
Friedreich Ataxia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 24
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Santhera Pharmaceuticals Holding AG, 2011* 25
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen Inc, 2011* 26
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Edison Pharmaceuticals, Inc., 2011* 27
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Penwest Pharmaceuticals Co., 2011* 28
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2011* 29
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by ApoPharma, 2011* 30
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Apotex, Inc., 2011* 31
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2011* 32
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of South Florida, 2011* 33
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Federico II University, 2011* 34
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Free Hampstead NHS Trust, 2011* 35
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2011* 36
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2011* 37
Friedreich Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Murdoch Childrens Research Institute, 2011* 38

List of Figures


Friedreich Ataxia Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Friedreich Ataxia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Friedreich Ataxia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Friedreich Ataxia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 11
Friedreich Ataxia Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 12
Friedreich Ataxia Therapeutics Clinical Trials, G7 Countries (%), 2011* 13
Friedreich Ataxia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 14
Friedreich Ataxia Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 15
Friedreich Ataxia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 16
Friedreich Ataxia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 17
Friedreich Ataxia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Friedreich Ataxia Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 21
Friedreich Ataxia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 23
Friedreich Ataxia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 24
GlobalData Methodology 79

Upcoming Reports:

Nano-biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
The branch of nanotechnology that deals with the study of biological and biochemical applications is known as nano-biotechnology. The study indulges mostly into deeply classifying the elements of living things or organisms and then modifying the same into nano products. Nano-biotechnology is a vital element boosting the new developments in the field of biotechnology. Biological research coupled with nano-technology continuously leads to the development of new inventions.  The formulation of concepts in nano-biotechnology involves the following: Devices...
Polymerase Chain Reaction (PCR) Technologies And Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012 - 2018
By - Transparency Market Research
Polymerase chain reaction (PCR) is a simple and rapid method to amplify DNA, i.e. produce a large number of clones of DNA molecules from a sample. In the fields of molecular biology or molecular pathology, where the sample quality might be poor, PCR has become the most widely used technology. The market for PCR technology  includes reagents and consumables, instruments, software and services. The reagents and consumables segment accounts for the largest share in this market, followed by the instruments segment. Growth of this market is fuelled by increased usage and wide...
FAME (Fatty Acid Methyl Esters) - Global Industry Analysis, Market Share, Size, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Fatty acid methyl esters (FAME) are produced by reacting fatty acids and methanol. They are also present in biodiesels and are similar to those in conventional diesel but expel lower concentrations of toxic emissions and thus, are non-toxic and biodegradable. They are produced from vegetable oils and animal fats by the process of transesterification. Rapeseed, soybean, UCO, palm oils, sunflower and animal fat are used as raw materials for the production of FAME. FAME have high oxidation stability and hence can be used under normal conditions. The use of these esters...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...